Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Dundee Corporation (TSX:DC.A) announces that, through its wholly owned subsidiary, Dundee Resources Limited, it...
-
ADVISORY, Feb. 08, 2018 (GLOBE NEWSWIRE) -- What: Blacks at Microsoft (BAM), a company-sponsored employee network dedicated to supporting the continued growth and development of black employees...
-
LIVONIA, Mich., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...
-
LOUISVILLE, Ky., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI”) (NASDAQ:CHDN) today announced the preliminary results of its “modified Dutch auction” tender offer, which...
-
ADVISORY, Feb. 08, 2018 (GLOBE NEWSWIRE) -- What: Victory Capital Holdings, Inc. (“Victory Capital”) (Nasdaq:VCTR), an integrated multi-boutique asset management firm, will visit the Nasdaq...
-
SAN JOSE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Broadcom Limited (NASDAQ:AVGO) (“Broadcom” or the “Company”) announced today that the pending offer by two of its subsidiaries, Broadcom...
-
HOUSTON, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Sanchez Energy Corporation (“Sanchez Energy” or the “Company”) announced today that it has priced its private offering to eligible purchasers of $500...
-
LA JOLLA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
-
TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to announce that it has...
-
LIVONIA, Mich., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...